Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
Healthcare
$18.98 -0.05%
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
52W Low $15.35High $20.30
Volume 0.37M
Average 0.43M
ODTX Total Liabilities
Everything the company owes to creditors and other parties.
No reported Total Liabilities figures are available to summarize.
Total Liabilities history
Currency unavailable · from the balance sheet
No Total Liabilities data reported for this period type.
Total Liabilities vs competitors
How ODTX compares with its peers on the latest reported figures
ODTX Competitors
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $316.94M USD | -18.3% | -2.1% | 96.1% | |
ALMSAlumis Inc. Common Stock | Jun 2026 | $108.46M USD | -13.6% | -28.6% | 19.3% |
| Mar 2026 | $55.07M USD | +1.9% | +0.2% | 27.7% | |
| Sep 2026 | $48.19M USD | -2.6% | +44.2% | 4.4% | |
| Jun 2026 | $44M USD | -12.0% | +19.5% | 5.0% | |
| Mar 2026 | $38.51M USD | +49.2% | +29.7% | 20.3% | |
ORKAOruka Therapeutics, Inc. | Sep 2026 | $33.88M USD | +50.8% | +127.8% | 2.8% |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €18.7M EUR | — | — | 11.3% |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | -2.6% | +19.5% | 15.3% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Currency unavailable
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.